Market revenue in 2022 | USD 491.6 million |
Market revenue in 2030 | USD 733.5 million |
Growth rate | 5.1% (CAGR from 2022 to 2030) |
Largest segment | Dietary supplements |
Fastest growing segment | Dietary Supplements |
Historical data | 2018 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | OTC pharma products, Dietary Supplements |
Key market players worldwide | Bayer AG, AbbVie Inc, Abbott Laboratories, Nestle SA, Dr Reddy's Laboratories Ltd ADR, Theramex, Rainbow Light Nutritional Systems, Padagis |
Dietary supplements was the largest segment with a revenue share of 94.75% in 2024. Horizon Databook has segmented the Italy menopause market based on otc pharma products, dietary supplements covering the revenue growth of each sub-segment from 2018 to 2030.
The number of women opting for Hormone Replacement Therapy (HRT) is low and the adoption of food supplements is increasing in the country. According to a study published by Minerva Medica, in December 2015, only 6%–8% of women opted for HRT for insomnia and hot flashes. Moreover, studies are being conducted to check the effects of supplements in menopause.
In April 2016, Natural Product Communications published a study that mentioned soy germ might help improve menopausal symptoms, especially the occurrence of insomnia, sexual dysfunction, and hot flashes. The low adoption of HRT for menopause, along with studies supporting dietary supplements for easing menopausal symptoms, is expected to positively impact the market in the country.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account